A highly potent CD73 biparatopic antibody blocks organization of the enzyme active site through dual mechanisms.
Ontology highlight
ABSTRACT: The dimeric ectonucleotidase CD73 catalyzes the hydrolysis of AMP at the cell surface to form adenosine, a potent suppressor of the immune response. Blocking CD73 activity in the tumor microenvironment can have a beneficial effect on tumor eradication and is a promising approach for cancer therapy. Biparatopic antibodies binding different regions of CD73 may be a means to antagonize its enzymatic activity. A panel of biparatopic antibodies representing the pairwise combination of 11 parental monoclonal antibodies against CD73 was generated by Fab-arm exchange. Nine variants vastly exceeded the potency of their parental antibodies with ≥90% inhibition of activity and subnanomolar EC50 values. Pairing the Fabs of parents with nonoverlapping epitopes was both sufficient and necessa
SUBMITTER: Stefano JE
PROVIDER: S-EPMC7939394 | biostudies-literature | 2020 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA